Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shufeng Zhike Mixture for post-infectious cough (fengxie loves the lung syndrome)
ChiCTR2100048649Phase 3Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2021
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postinfectious cough comparing Test group – Shufeng Zhike Mixture with Control group – placebo (2 arms). Primary endpoint: cough disappearance rate. Planned start Apr 2021; status: not yet recruiting.
02
Drugs
Shufeng Zhike Mixture
03
Conditions
postinfectious cough
Beyond the preview
Go deeper on ChiCTR2100048649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048649.